tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Valneva Announces Positive Phase 2 Results for Chikungunya Vaccine in Children
PremiumCompany AnnouncementsValneva Announces Positive Phase 2 Results for Chikungunya Vaccine in Children
2M ago
Valneva says IXCHIQ ‘well tolerated’ by children ages 1-11 years
Premium
The Fly
Valneva says IXCHIQ ‘well tolerated’ by children ages 1-11 years
2M ago
Valneva Prepares for Shareholder Meeting and Announces Leadership Change
Premium
Company Announcements
Valneva Prepares for Shareholder Meeting and Announces Leadership Change
2M ago
Valneva Reports Strong Q1 2025 Results and Advances Vaccine Portfolio
PremiumCompany AnnouncementsValneva Reports Strong Q1 2025 Results and Advances Vaccine Portfolio
3M ago
Valneva says EMA started Ixchiq review after reports of SAEs
Premium
The Fly
Valneva says EMA started Ixchiq review after reports of SAEs
3M ago
Valneva’s Chikungunya Vaccine Use Suspended for Elderly Amid Safety Concerns
Premium
Company Announcements
Valneva’s Chikungunya Vaccine Use Suspended for Elderly Amid Safety Concerns
3M ago
Valneva granted marketing authorization for Ixchiq in Brail
PremiumThe FlyValneva granted marketing authorization for Ixchiq in Brail
4M ago
Positive Outlook for Valneva Driven by Promising Vaccine Pipeline and Strategic Developments
Premium
Ratings
Positive Outlook for Valneva Driven by Promising Vaccine Pipeline and Strategic Developments
4M ago
Valneva and LimmaTech Initiate Phase 2 Study of Shigella Vaccine
Premium
Company Announcements
Valneva and LimmaTech Initiate Phase 2 Study of Shigella Vaccine
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100